Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1901 1
1924 1
1926 1
1927 2
1928 2
1930 1
1932 1
1933 1
1934 1
1935 1
1937 1
1938 2
1942 1
1945 1
1946 1
1947 2
1950 1
1951 1
1952 1
1954 2
1956 3
1957 5
1958 3
1959 5
1960 4
1961 7
1962 7
1963 11
1964 14
1965 13
1966 9
1967 10
1968 12
1969 12
1970 11
1971 17
1972 20
1973 6
1974 7
1975 13
1976 16
1977 11
1978 10
1979 20
1980 7
1981 20
1982 9
1983 20
1984 21
1985 15
1986 10
1987 12
1988 20
1989 17
1990 17
1991 16
1992 14
1993 15
1994 14
1995 11
1996 21
1997 22
1998 15
1999 36
2000 24
2001 15
2002 20
2003 26
2004 23
2005 16
2006 31
2007 36
2008 36
2009 36
2010 43
2011 71
2012 45
2013 61
2014 51
2015 76
2016 63
2017 74
2018 97
2019 101
2020 109
2021 113
2022 114
2023 128
2024 117
2025 38

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,960 results

Results by year

Filters applied: . Clear all
Page 1
Emerging therapeutic agents for advanced non-small cell lung cancer.
Chen R, Manochakian R, James L, Azzouqa AG, Shi H, Zhang Y, Zhao Y, Zhou K, Lou Y. Chen R, et al. Among authors: james l. J Hematol Oncol. 2020 May 24;13(1):58. doi: 10.1186/s13045-020-00881-7. J Hematol Oncol. 2020. PMID: 32448366 Free PMC article. Review.
Intracellular Antiviral Immunity.
Bottermann M, James LC. Bottermann M, et al. Among authors: james lc. Adv Virus Res. 2018;100:309-354. doi: 10.1016/bs.aivir.2018.01.002. Epub 2018 Feb 16. Adv Virus Res. 2018. PMID: 29551141 Free PMC article. Review.
Authors' Reply.
Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekman F, Cross N, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au E, Kieu A, James L, Craig JC. Wong G, et al. Among authors: james l. J Am Soc Nephrol. 2019 Nov;30(11):2276-2277. doi: 10.1681/ASN.2019090889. Epub 2019 Oct 9. J Am Soc Nephrol. 2019. PMID: 31597717 Free PMC article. No abstract available.
Acetaminophen-induced hepatotoxicity.
James LP, Mayeux PR, Hinson JA. James LP, et al. Drug Metab Dispos. 2003 Dec;31(12):1499-506. doi: 10.1124/dmd.31.12.1499. Drug Metab Dispos. 2003. PMID: 14625346 Review.
Target class drug discovery.
Barnash KD, James LI, Frye SV. Barnash KD, et al. Among authors: james li. Nat Chem Biol. 2017 Sep 19;13(10):1053-1056. doi: 10.1038/nchembio.2473. Nat Chem Biol. 2017. PMID: 28926557 Free PMC article.
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.
Shaw AT, Felip E, Bauer TM, Besse B, Navarro A, Postel-Vinay S, Gainor JF, Johnson M, Dietrich J, James LP, Clancy JS, Chen J, Martini JF, Abbattista A, Solomon BJ. Shaw AT, et al. Among authors: james lp. Lancet Oncol. 2017 Dec;18(12):1590-1599. doi: 10.1016/S1470-2045(17)30680-0. Epub 2017 Oct 23. Lancet Oncol. 2017. PMID: 29074098 Free PMC article. Clinical Trial.
TRIM21-From Intracellular Immunity to Therapy.
Foss S, Bottermann M, Jonsson A, Sandlie I, James LC, Andersen JT. Foss S, et al. Among authors: james lc. Front Immunol. 2019 Aug 28;10:2049. doi: 10.3389/fimmu.2019.02049. eCollection 2019. Front Immunol. 2019. PMID: 31555278 Free PMC article. Review.
1,960 results